Purpose The aim of this review was to provide all the pharmacokinetic data for semaglutide
in humans concerning its pharmacokinetics after subcutaneously and oral applications in …

Obesity and type 2 diabetes mellitus have become a significant public health problem in the
past decades. Their prevalence is increasing worldwide each year, greatly impacting the …

Diabetes mellitus is a chronic multisystem disease with a high global prevalence. The
glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is known to lower glucose …

Given their endemic prevalence in the past decades, obesity and type 2 diabetes mellitus
(T2DM) have become a major sanitary burden with an important economic impact. Novel …

Type 2 diabetes (T2D) and obesity are known as important chronic diseases in the world. A
common mechanism of pathogenesis in both diseases is the dysregulation of the insulin …

Background The burgeoning prevalence of Type 2 Diabetes Mellitus (T2DM) has been
linked to a spectrum of health complications, including those affecting the musculoskeletal …

Abstract Glucagon like peptide-1 (GLP-1) receptor agonists are a group of hypoglycemic
drugs that are used primarily to treat type 2 diabetes both as monotherapy and in …

Introdução: A obesidade é uma doença com prevalência crescente, com complicações
debilitantes, que se associam a elevada morbimortalidade e a um compromisso da …

Flavanols, in particular (−)-epicatechin (EC) and anthocyanins (ACs), are among the most
abundant plant food bioactives present in the diet. Both epidemiological and clinical dietary …

Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that is released upon
nutrient ingestion stimulating insulin secretion, suppressing glucagon secretion, and …